How to Know If You Need a Colonoscopy: Signs and Symptoms

Certain symptoms, your age, and your personal medical history each independently create reasons to get a colonoscopy, and sometimes all three overlap. The clearest red flags are rectal bleeding, unexplained changes in bowel habits, persistent abdominal pain, and iron-deficiency anemia. But many people who need a colonoscopy have no symptoms at all and qualify purely because of their age or family background. Understanding which category you fall into matters, because colorectal cancer is far more treatable when caught early and far more dangerous when people wait.

Symptoms That Should Send You to Your Doctor

Four warning signs consistently show up in the research as linked to colorectal cancer risk: rectal bleeding, abdominal pain, diarrhea, and iron-deficiency anemia. A large case-control study found that even three months to two years before a diagnosis, these signs were already associated with increased risk of early-onset colorectal cancer, with the odds climbing sharply when more than one symptom was present. People with just one of these symptoms had roughly double the risk compared to people with none, while those with three or more had more than six times the risk.1PubMed Central. Red-flag signs and symptoms for earlier diagnosis of early-onset colorectal cancer The association was even stronger in younger adults.

Rectal bleeding is the symptom most people notice first, and with good reason. In a study of symptomatic adults in Oman, rectal bleeding roughly doubled the odds of finding advanced colorectal neoplasia, as did abdominal pain.2PubMed Central. Age-Specific Colonoscopic Yield and Symptom-Based Risk Stratification in Symptomatic Adults Blood in or on your stool, whether bright red or dark, is never something to write off as “just hemorrhoids” without investigation. A doctor may still conclude hemorrhoids are the cause, but that conclusion should come after evaluation, not before.

A persistent change in bowel habits, such as new-onset diarrhea, constipation, or a noticeable shift in stool caliber lasting more than a few weeks, is another reason to bring it up. Interestingly, a change in bowel habit alone carried different weight depending on age. In a study of over 600 patients referred for that symptom, none of the patients under 55 who had only a change in bowel habit (without bleeding or anemia) turned out to have colorectal cancer. But in people 55 and older, the rate climbed with each decade. When a bowel-habit change was combined with anemia or bleeding, colorectal cancer was found in about 16% of people under 55 and about 30% of those 55 and older.3PubMed Central. The diagnostic value of a change in bowel habit for colorectal cancer within different age groups

Unexplained weight loss and persistent fatigue round out the broader symptom picture. Iron-deficiency anemia in particular deserves attention because it can be the only early clue. You might not see blood in your stool, but a slow-bleeding lesion in the colon can gradually drain your iron stores, leaving you tired and pale. If your doctor discovers low iron without an obvious dietary or menstrual explanation, a colonoscopy is a standard next step.

Age-Based Screening When You Feel Fine

You do not need symptoms to need a colonoscopy. The whole point of screening is to find problems before they cause symptoms, because by the time colorectal cancer produces noticeable signs, it may already be advanced. The U.S. Preventive Services Task Force recommends that average-risk adults begin screening at age 45 and continue through age 75. Modeling estimates suggest that starting at 45 instead of 50 averts roughly two to three additional colorectal cancer cases per 1,000 people screened and adds about 22 to 27 life-years per 1,000 adults, which works out to roughly eight to ten extra days of life per person.4Journal of the American Medical Association. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement Those numbers sound modest at the population level, but for the individual whose cancer gets caught early, the benefit is enormous.

Cost-effectiveness analyses support the shift to age 45 as well. Whether the initial screen is a colonoscopy or a stool-based test, starting five years earlier was found to reduce both colorectal cancer incidence and mortality at a cost considered acceptable by standard health-economic thresholds.5PubMed. The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population

If you are between 45 and 75 and have never been screened, you are overdue. If you are between 76 and 85, the decision becomes more individual, depending on your overall health and prior screening history. Beyond 85, most guidelines recommend stopping. The decision about when to stop is worth a full discussion on its own.

Why Younger Adults Are Getting Diagnosed More Often

One of the more alarming trends in oncology over the past two decades is the rise in early-onset colorectal cancer, defined as cases diagnosed before age 50. These cancers tend to show up in the distal colon or rectum and often present with the same red-flag symptoms already discussed: blood in the stool, abdominal pain, altered bowel habits, and iron-deficiency anemia.6PubMed Central. Closing the Diagnostic Gap in Early-Onset Colorectal Cancer: Red-Flag Symptoms, Screening, and Inherited Risk The problem is that younger patients and their doctors are less likely to suspect cancer, which leads to delays.

A cohort study from Mexico found that the median time from symptom onset to treatment in early-onset cases was about 243 days, or roughly eight months. Two-thirds of patients with available data waited more than six months, and more than a third waited over three months just for the diagnosis itself. By the time treatment started, about 78% had advanced-stage disease.7PubMed Central. Prolonged Diagnostic Pathways and Advanced-Stage Presentation in Early-Onset Colorectal Cancer: A Mexican Cohort Study This is not because the cancer is inherently more aggressive in younger people. It is largely because symptoms get attributed to something less serious for too long.

If you are under 45 and experiencing any combination of the warning signs described above, particularly rectal bleeding or iron-deficiency anemia, do not let age give you or your doctor false reassurance. A referral for colonoscopy outside of routine screening age is entirely appropriate when symptoms warrant it.

Family History and Inherited Risk

Your family tree can move you into a higher-risk category that requires earlier and more frequent colonoscopies. Having a first-degree relative (parent, sibling, or child) who was diagnosed with colorectal cancer is one of the most consistent risk markers. Guidelines generally recommend that people with a family history begin screening earlier and repeat it more often than the average-risk population.8PubMed. Colonoscopy in patients with a family history of colorectal cancer The specifics depend on how many relatives were affected and at what age they were diagnosed. If a first-degree relative was diagnosed before 60, you usually need to start screening at 40 or ten years before their age at diagnosis, whichever comes first.

At the far end of inherited risk sit defined genetic syndromes like Lynch syndrome, also called hereditary nonpolyposis colorectal cancer. People with Lynch syndrome carry mutations that dramatically increase their lifetime risk of colorectal cancer and several other cancers. A large Canadian registry study found that colonoscopy every one to two years is effective at detecting precancerous adenomas and reducing cancer risk in this group, though interestingly, more than half of Lynch syndrome patients in the study never developed an adenoma at all.9PubMed Central. Evaluating colonoscopy screening intervals in patients with Lynch syndrome from a large Canadian registry A national cohort study from the English health system echoed this, finding that surveillance colonoscopy at intervals of three years or less was associated with reduced colorectal cancer-specific mortality in Lynch syndrome patients.10Journal of Clinical Oncology. Impact of surveillance colonoscopy on colorectal cancer incidence and mortality in Lynch syndrome

If you know your family carries Lynch syndrome, familial adenomatous polyposis, or another inherited condition linked to colorectal cancer, your screening schedule will be far more aggressive than what applies to average-risk adults. If you have a strong family history but have never been tested for a genetic syndrome, that conversation with your doctor is overdue too.

Inflammatory Bowel Disease Changes the Timeline

Long-standing ulcerative colitis and Crohn’s disease that affects the colon are well-established risk factors for colorectal cancer. The longer and more extensive the inflammation, the higher the risk. Surveillance colonoscopy in this group typically begins about eight to ten years after diagnosis of colitis and recurs on a schedule tailored to individual risk factors: how much of the colon is inflamed, whether you have a family history of colorectal cancer, whether you also have primary sclerosing cholangitis, and whether any prior colonoscopies have found dysplasia.11Gastroenterology. Endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases (IBD)

Different guidelines around the world set slightly different intervals. Japanese and American guidelines lean toward annual or biannual colonoscopy for ulcerative colitis patients, while British and European guidelines stratify by risk, with the highest-risk patients getting yearly exams and lower-risk patients examined every three to five years.12PubMed. Surveillance colonoscopy for colitis-associated dysplasia and cancer in ulcerative colitis patients If you have IBD, your gastroenterologist should already have a surveillance plan in place. If they have not mentioned one, ask about it.

When Symptoms Get Blamed on Something Else

One of the most frustrating patterns in colorectal cancer diagnosis is how frequently early symptoms are attributed to benign conditions. A primary-care study found that patients who were female, lacked what clinicians considered “alarm” symptoms, or had hemorrhoids found on physical exam were at risk for longer delays before being referred for further workup. The researchers identified two recurring themes in delayed cases: doctors settling on an alternative diagnosis too early and failing to reconsider it when symptoms persisted, and a lack of structured follow-up to ensure the initial diagnosis was actually correct.13PubMed Central. Potential for Reducing Time to Referral for Colorectal Cancer Patients in Primary Care

Hemorrhoids are probably the single biggest decoy. They are extremely common, they do cause rectal bleeding, and in most cases they are the correct explanation. But when a doctor finds hemorrhoids and stops looking, they can miss a cancer further up the colon. The same goes for irritable bowel syndrome, which shares symptoms like abdominal pain and altered bowel habits with colorectal cancer but does not carry the same risk. If your symptoms are not improving with treatment for the presumed benign diagnosis, push for further investigation. A colonoscopy is the definitive way to rule out something more serious.

Non-Invasive Tests and What a Positive Result Means

Colonoscopy is the gold standard for both finding and removing precancerous polyps, but it is not the only front door to screening. Stool-based tests are widely used as an initial screen, and they are a perfectly valid choice for average-risk adults who are up to date on screening. The fecal immunochemical test (FIT) checks for hidden blood in your stool and has largely replaced the older guaiac-based test because of better accuracy and lower cost.14PubMed Central. Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests Multi-target stool DNA tests, which combine FIT with molecular markers, have higher sensitivity for detecting cancer but cost more and have slightly more false positives.

Newer approaches are pushing the frontier. Researchers are exploring methylation markers in stool DNA. One validation study found that combining a methylated syndecan-2 test with FIT pushed sensitivity for detecting colorectal cancer to about 96% with specificity around 82%.15PubMed Central. A Validation Study of Methylated Syndecan-2 in Stool DNA for the Detection of Colorectal Cancer Blood-based tests using circulating tumor DNA are also in development as a non-invasive surveillance option, though this field is still maturing.16Journal of Clinical Oncology. Diagnostic accuracy of circulating tumor DNA for early detection of colorectal cancer: A systematic review and meta-analysis

Here is the critical point about all non-invasive tests: a positive result means you need a colonoscopy. The stool test flags that something may be wrong; the colonoscopy is what confirms or rules out the problem. And timing matters. A study of over 70,000 patients found that delaying colonoscopy after a positive FIT did not significantly raise the risk of cancer outcomes if follow-up happened within about six months. But by seven to nine months, a non-significant increase appeared, and by ten months or longer, the risk of both any colorectal cancer and advanced-stage disease was significantly higher.17PubMed Central. Association Between Time to Colonoscopy After a Positive Fecal Test and Risk of Colorectal Cancer Stage at Diagnosis A separate analysis found that delays beyond 12 months nearly doubled the odds of cancer outcomes, and delays of 19 to 21 months were associated with a 52% higher risk of dying from colorectal cancer compared with follow-up within three months.18PubMed Central. Rates and Timing of Follow-up Colonoscopy After a Positive Stool-Based Test in an Integrated Health System

If your stool test comes back positive, schedule the colonoscopy promptly. This is not the moment to procrastinate.

What Happens After Polyps Are Found

Finding polyps during a colonoscopy does not necessarily mean anything is wrong right now, but it does set the clock for your next one. The follow-up interval depends on what was found, how many, and how big. Current guidelines lay this out in detail: if your doctor removed one or two small tubular adenomas (the most common type), you can wait seven to ten years for your next colonoscopy. Three or four small adenomas shorten that to three to five years. If any polyp was 10 millimeters or larger, had villous features, or showed high-grade dysplasia, the interval drops to three years. And if more than ten adenomas were found, a repeat in just one year is recommended.19Gastroenterology. Follow-up after colonoscopy and polypectomy

These intervals assume the initial colonoscopy was high quality, meaning the entire colon was adequately visualized and all polyps were completely removed. If the bowel preparation was poor and your doctor could not see the lining clearly, a sooner repeat may be necessary. That said, the relationship between prep quality and detection rates is more nuanced than many people assume. A meta-analysis found that the difference in adenoma detection between intermediate-quality and high-quality preparation was not statistically significant. The real drop-off happened only with genuinely poor prep, where detection rates were meaningfully lower.20PubMed Central. What level of bowel prep quality requires early repeat colonoscopy: systematic review and meta-analysis of the impact of preparation quality on adenoma detection rate So if your prep was fair but not perfect, the exam is still likely valid. Only a truly inadequate prep justifies doing it all over again soon.

Risks of the Procedure

Colonoscopy is generally safe, but it is not risk-free, and it is reasonable to weigh those risks before deciding. The two main complications are bleeding and perforation (a small tear in the colon wall). In a large French study, perforation rates ranged from about 3.5 to 7.3 per 10,000 procedures depending on how strictly the complication was defined, and bleeding rates ranged from about 6.5 to 23 per 10,000. Splenic injury was rare, at roughly 0.2 to 0.3 per 10,000. The risk of dying within 30 days of a complication was highest for splenic injuries and perforations, though even those events were uncommon.21Clinical Gastroenterology and Hepatology. Incidence and Risk Factors for Rectal and Colonic Complications Associated With Screening and Diagnostic Colonoscopy in France

Several factors raise the risk. Having polyps removed, especially large ones, increases the chance of both bleeding and perforation. Taking blood thinners or antiplatelet drugs adds to the bleeding risk.22PubMed. Risk of colonoscopy-related complications in a fecal immunochemical test-based population colorectal cancer screening program A history of pelvic surgery or abdominal radiation therapy is a strong independent risk factor for complications, particularly perforation. And studies consistently find that less-experienced endoscopists have higher complication rates, so if you are in a position to choose, a high-volume provider is worth seeking out.23PubMed. Risk factors for severe complications of colonoscopy in screening programs

For most healthy adults getting a routine screening colonoscopy, the absolute risk of a serious complication is well under 1%. The risk-benefit math overwhelmingly favors screening in the recommended age range. But the calculus shifts as you get older or sicker, which is why the question of when to stop screening deserves real thought.

When Screening No Longer Makes Sense

The benefits of colonoscopy come with a time delay. It takes years for a detected polyp removal to translate into a prevented cancer, which means the procedure is most valuable for people likely to live long enough to benefit. A modeling study that examined the balance of harms and benefits found that the optimal age to stop screening ranged enormously depending on health status and screening history. For an unhealthy person who has had regular screening throughout their life, the balance tipped toward stopping around age 66. For a healthy person who had never been screened before, the benefit could extend to age 90.24PubMed Central. Calculation of Stop ages for Colorectal Cancer Screening Based on Comorbidities and Screening History

That wide range underscores a point worth remembering throughout this entire discussion: screening recommendations are population-level averages, and your personal situation can move the needle significantly in either direction. A 70-year-old with no major health problems who has never had a colonoscopy is in a very different position from a 70-year-old with heart failure and a string of clean colonoscopies. The conversation with your doctor should reflect that. If you are over 75 and someone suggests a colonoscopy, it is entirely appropriate to ask whether the expected benefit justifies the risks and the prep for someone in your specific state of health.